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Abstract
Gastric intestinal metaplasia is clinically relevant because of its role in the process of gastric carcinogenesis. The current gold
standard for the diagnosis of intestinal metaplasia is histology. It may be recognized on standard white-light endoscopy as
whitish plaques, and a villous appearance may even be evident with high-deﬁnition white-light endoscopy without
magniﬁcation. However, standard white-light endoscopy is generally suboptimal for endoscopic diagnosis because intes-
tinal metaplasia usually appears in ﬂat mucosa and shows few morphological changes. Techniques of image-enhanced
endoscopy, especially in the setting of magnifying endoscopy with high deﬁnition, are useful in the detection of such
lesions and will permit targeted biopsies. This video review will demonstrate the typical appearance of intestinal metaplasia
on white-light endoscopy, with methylene blue chromoendoscopy and narrow-band imaging. This article is part of an
expert video encyclopedia.
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Video Related to this Article
Techniques
White-Light Endoscopy
After the gastroscope is inserted into the stomach, any overlying
mucus is ﬂushed away by rinsing with water, which is then
aspirated. Alternatively, 0.04% simethicone solution has also
been used for rinsing the mucosal surface. The antrum, incisura,
and corpus are carefully examined. Gastric intestinal metaplasia
will appear as mildly elevated whitish plaques. If a high-
deﬁnition gastrovideoscope system is used, the villous surface
may even be evident without the use of magniﬁcation.
Chromoendoscopy1
A spray catheter is inserted into the working channel of the
gastroscope, extending 2–3 cm beyond the distal end of the
gastroscope. Staining is performed by directing the spray
catheter tip toward the mucosa and spraying 10–20 ml of the
dye while rotating the shaft of the endoscope and simul-
taneously slowly withdrawing the endoscope. Indigo carmine
at a concentration of 0.1–0.8% is used to provide contrast
staining. It will make any mucosal surface irregularity (either
erosions or elevations) more obvious, and when used in
conjunction with optical magniﬁcation, will facilitate exam-
ination of the pit pattern of the lesion. Methylene blue is an
absorptive dye that stains absorptive intestinal-type metaplasia
of the stomach. After pretreating the mucosa with a mucolytic
agent, spraying of 0.5% methylene blue is performed, fol-
lowed by a dwell time of 1–2 min, and vigorously washing the
excess dye with tap water until persistent blue staining re-
mains. The areas of stained blue are the sites of intestinal
metaplasia.
Narrow-Band Imaging
Narrow-band imaging (NBI) is available with both the Exera II
and Lucera systems. The NBI mode is switched on simply by
pressing a button on the gastroscope. The Lucera system will
allow optical magniﬁcation, whereas the Exera II system per-
mits digital magniﬁcation. Owing to darker illumination
when the NBI mode is switched on, the tip of the gastroscope
has to be moved closer to the gastric mucosal surface. In the
newly launched Exera III system, the illumination is brighter
and it is possible to visualize the mucosal surface clearly even
from a distance. With NBI, areas of intestinal metaplasia will
appear as bluish–whitish patchy areas. This is particularly
useful because this may not be evident by white-light en-
doscopy at all. There may also be areas of light blue crest,
which are blue-white lines visible on the epithelial surface.
With further magniﬁcation, the villous appearance will be
evident.
Equipment and Materials
• White-light endoscopy: any standard gastrovideoscope.
• NBI: Either the Exera II or Exera III systems or the Lucera
system (Olympus Co., Tokyo, Japan). The Lucera system
allows for optical magniﬁcation.
• Chromoendoscopy:
J Indigo carmine: 0.1–0.8% solution.
J Methylene blue solution: 0.5% solution.
• Spray catheter.
This article is part of an expert video encyclopedia. Click here for the full
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Background and Endoscopic Procedures
Gastric intestinal metaplasia is clinically relevant because of its
role in the process of gastric carcinogenesis, where it has been
proposed that the intestinal type of gastric adenocarcinoma is
the end result of progressive changes in the gastric mucosa.
The gastric mucosa undergoes progressive changes from
superﬁcial gastritis, to multifocal atrophic gastritis, to intes-
tinal metaplasia, to dysplasia, and ﬁnally adenocarcioma.2 In
a Japanese trial of 1246 patients with both Helicobacter pylori
infection and intestinal metaplasia (IM) followed for a mean
follow-up of 7.8 years, intestinal metaplasia was associated
with a relative risk of 6.4.3 A Dutch study assessed the role of
IM in gastric cancer development in a cohort of 61 707 pa-
tients with intestinal metaplasia. The cumulative 10-year in-
cidence of gastric cancer was 1.8%, with an estimated yearly
incidence of 0.18%.3 When so-called prevalent cases diag-
nosed within 10.8 months of follow-up were excluded, the 10-
year incidence rate was 1.1% (0.11% yearly).4
The current gold standard for the diagnosis of intestinal
metaplasia is histology. It may be recognized on standard
white-light endoscopy as whitish plaques, and a villous ap-
pearance may even be evident with high-deﬁnition white-light
endoscopy without magniﬁcation. However, standard white-
light endoscopy is generally suboptimal for endoscopic diag-
nosis because intestinal metaplasia usually appears in ﬂat
mucosa and shows few morphological changes. Techniques of
image-enhanced endoscopy, especially in the setting of mag-
nifying endoscopy with high deﬁnition, are useful in the de-
tection of such lesions and will permit targeted biopsies.
Indigo carmine chromoendoscopy is useful to outline any
mucosal surface irregularity, and when used in conjunction
with optical magniﬁcation, will facilitate examination of the
pit pattern of the lesion. It is not speciﬁc to intestinal meta-
plasia. Methylene blue is an absorptive dye that stains ab-
sorptive intestinal type metaplasia of the stomach. Methylene
blue staining with magniﬁcation endoscopy has been shown
to detect gastric intestinal metaplasia and dysplasia with 84%
and 83% accuracy, respectively.5
NBI facilitates examination of the mucosal surface without
a need for chromoendoscopy. In NBI, a rotating interference
narrow-band ﬁlter is interposed after the xenon light source,
such that when the NBI mode is switched on, discrete blue
and green wavelengths are used, and this facilitates visual-
ization of mucosal details. Gastric intestinal metaplasia is
recognized in NBI as bluish–whitish patchy areas. This is
particularly useful because this may not be evident by white-
light endoscopy at all. There may also be areas of light blue
crest,6,7 which are blue–white lines visible on the epithelial
surface. The speciﬁcity of the light blue crest for intestinal
metaplasia has been reported to range from 87%7 to 93%.6
With further magniﬁcation, the villous appearance will be
evident. NBI has been reported to increase the detection rate
of gastric intestinal metaplasia.7
Key Learning Points
• Before examination of the gastric mucosal surface, the
mucosa should be rinsed to remove overlying mucus.
• When performing NBI using the Exera II system, the tip of
the gastroscope should be brought close to the mucosal
surface because of the dark illumination.
• To perform magnifying endoscopy with either chro-
moendoscopy or NBI, a disposable attachment should be
ﬁtted to the scope tip to maintain an adequate distance
from the mucosa for magnifying observation.
Scripted Voiceover
Time
(min:sec)
Voiceover text
0:00–0:20 Under white light endoscopy, obvious areas of mucosal
irregularity are seen at the antral and incisural regions.
0:21–0:48 Using narrow-band imaging, these areas appear bluish-
white, which is characteristic of gastric intestinal
metaplasia.
0:49–0:57 Here, multiple, patchy, and ﬂat erythematous lesions at
the antrum are seen on white light endoscopy.
0:58–1:25 Narrow-band imaging demonstrates the typical bluish-
white appearance of gastric intestinal metaplasia.
1:26–2:03 In this patient, subtle focal lesions are seen at the antrum
and incisura.
2:04–2:43 Under narrow-band imaging, the characteristics of the
lesions are accentuated. The classical bluish-white
appearance of gastric intestinal metaplasia is depicted.
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